title: Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction.
abstract: To determine whether the presence of hepatitis C virus (HCV) viremia correlates with the severity of liver disease in anti-HCV-positive apparently healthy blood donors, we studied 98 blood donors found positive for anti-HCV using enzyme-linked immunosorbent assay (ELISA). Each subject underwent a liver biopsy, a test for HCV RNA in the serum by polymerase chain reaction (PCR), and a panel of liver injury tests. As a result, 97% of the anti-HCV-positive blood donors had some type of histological abnormality:22 (22%) had minimal changes, 1 (1%) had chronic lobular hepatitis, 40 (41%) had chronic persistent hepatitis (CPH), and 32 (33%) had chronic active hepatitis (CAH). Only 3 subjects had a normal liver histology. HCV RNA was detectable in the serum in 65% of the anti-HCV-positive donors. HCV RNA in serum was detectable in none of the donors with a normal liver histology, in 36% (confidence interval [CI], 17% to 59%) of those with minimal changes, in 70% (CI, 53% to 83%) of those with CPH, and in 87% (CI, 71% to 96%) of those with CAH (P = .00001). HCV RNA was detectable in 75% of the donors with elevated (> 45 U/L) alanine transaminase (ALT) values and in 59% of those with normal ALT levels (P = not significant). The incidence of chronic hepatitis was higher in HCV RNA-positive than in HCV RNA-negative donors (88% vs. 50%; P = .00005).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Departments of Gastroenterology, Hospital Universitario La Fe, Valencia, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Prieto
authors.forename: V
authors.initials: V
authors.lastname: Olaso
authors.forename: C
authors.initials: C
authors.lastname: Verdú
authors.forename: J
authors.initials: J
authors.lastname: Córdoba
authors.forename: C
authors.initials: C
authors.lastname: Gisbert
authors.forename: M
authors.initials: M
authors.lastname: Rayón
authors.forename: D
authors.initials: D
authors.lastname: Carrasco
authors.forename: M
authors.initials: M
authors.lastname: Berenguer
authors.forename: M D
authors.initials: MD
authors.lastname: Higón
authors.forename: J
authors.initials: J
authors.lastname: Berenguer
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D001483:Base Sequence; D002353:Carrier State; D002908:Chronic Disease; D005260:Female; D016174:Hepacivirus / Q000235:genetics* / Q000276:immunology; D006526:Hepatitis C / Q000473:pathology / Q000821:virology*; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood*; D012307:Risk Factors
chemical_list: D000914:Antibodies, Viral; D012367:RNA, Viral; D000410:Alanine Transaminase